ZERKAI

Search documents
Telix Pharmaceuticals Ltd(TLX) - 2025 H1 - Earnings Call Transcript
2025-08-21 00:32
Telix Pharmaceuticals (TLX) H1 2025 Earnings Call August 20, 2025 07:30 PM ET Company ParticipantsKyahn Williamson - SVP - Corporate Communication & IRDarren Smith - Group CFOChristian Behrenbruch - MD, Group CEO & DirectorKevin Richardson - CEO - Telix Precision MedicineRichard Valeix - CEO - Telix TherapeuticsDavid Low - Executive DirectorNick Lorusso - VP - Biotech Equity ResearchDavid Dai - DirectorDavid Nierengarten - Managing Director - Equity ResearchConference Call ParticipantsAndy Hsieh - Research ...